Rasmus Wolff

CHAMA is a start-up whose mission is to provide Brazilian consumers a convenient alternative for ordering their cooking gas. Each month, Brazilians run out of their cooking gas, experiencing a very repetitive re-ordering process. Chama aims to empower all Brazilians by providing them a mobile platform from which consumers can choose their preferred dealer based on price, quality or ETA. Chama has big ambitions and is growing very rapidly! With a young and very motivated team based in Amsterdam and São Paulo, CHAMA is always looking for pioneers that aim to revolutionize this dinosaur of an industry. Are you up for the challenge? Have a look on https://chamatheapp.bamboohr.co.uk/jobs/

CHAMA is a start-up whose mission is to provide Brazilian consumers a convenient alternative for ordering their cooking gas. Each month, Brazilians run out of their cooking gas, experiencing a very repetitive re-ordering process. Chama aims to empower all Brazilians by providing them a mobile platform from which consumers can choose their preferred dealer based on price, quality or ETA. Chama has big ambitions and is growing very rapidly! With a young and very motivated team based in Amsterdam and São Paulo, CHAMA is always looking for pioneers that aim to revolutionize this dinosaur of an industry. Are you up for the challenge? Have a look on https://chamatheapp.bamboohr.co.uk/jobs/

At Hungr we passionately enjoy finding new ways to use technology to make everyday life easier and better for the connected generations. We love to create - to challenge conventions and to do things differently. Thats why we created the company in the first place. We will go the extra mile to provide hungry consumers with tasty food to their home - and we will do that in simpler way than anything in the market today.

JP/Politikens Hus er en af Danmarks førende medievirksomheder. Vores formål er at formidle oplysning, nyheder og debat til borgerne. Koncernens udgivelser tæller blandt andet Ekstra Bladet, Jyllands-Posten og Politiken samt nogle af Danmarks toneangivende erhvervsudgivelser. JP/Politikens Hus ejer 49,9 pct. af Dagbladet Børsen og står bag Finans og Watch Medier. Med JP/Politikens Forlag udgiver vi en række af Danmarks og Sveriges mest læste forfattere. Dertil ejer vi Danmarks første og største online boghandel med millioner af titler på hylderne i alle genrer og i alle formater - trykte bøger, e-bøger og lydbøger. JP/Politikens Hus beskæftiger 2.100 ansatte og havde i 2021 en omsætning på 3,3 mia. kr.

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 68,800 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html